Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 141 for “"HDACi"”.

  1. Proteins Involved in HDACi Induced Decay of ERBB2 Transcripts in Breast Cancer

    … to these agents. Histone deacetylase inhibitors (HDACi) are a powerful new class of epigenetic therapeutics that have demonstrated potent antitumor activity. However, there are several concerns that need to be addressed regarding the clinical usage of pan-HDACi therapeutics, such as the standard …

    dominican Repository record for Proteins Involved in HDACi Induced Decay of ERBB2 Transcripts in Breast Cancer (opens in a new tab)

  2. Δράση των αναστολέων των απακετυλασών των ιστονών (HDACI) στον καρκίνο του μαστού

    … inhibitors (Histone deacetylase inhibitors, HDACI) are already used in clinical practice to treat mainly hematological malignancies. However, in the case of breast cancer, the data remain incomplete. Aim: The aim of the present study is to evaluate the immunohistochemical expression of HDAC-2 …

    greece Repository record for Δράση των αναστολέων των απακετυλασών των ιστονών (HDACI) στον καρκίνο του μαστού (opens in a new tab)

  3. Oxidative Stress Based Strategies For Enhancing The Efficacy of Histone Deacetylase Inhibitors (Hdaci)

    Histone deacetylase inhibitors (HDACi) are anti-cancer drugs that primarily act upon acetylation of histones, however they also increase levels of intracellular reactive oxygen species (ROS). We hypothesized that agents that cause oxidative stress might enhance the efficacy of HDACi. To test this …

    uthsc Repository record for Oxidative Stress Based Strategies For Enhancing The Efficacy of Histone Deacetylase Inhibitors (Hdaci) (opens in a new tab)

  4. Investigation and validation of the functional role of sMEK1 acetylation in DNA damage repair and HDACi-mediated radiosensitisation

    … outcomes. Histone deacetylase inhibitors (HDACi) have emerged as effective, low toxicity radiosensitising agents, although the mechanism of radiosensitisation is not fully defined. This study investigates the radiosensitising effects of the HDAC inhibitor panobinostat (PAN) via a mechanism …

    oxford Repository record for Investigation and validation of the functional role of sMEK1 acetylation in DNA damage repair and HDACi-mediated radiosensitisation (opens in a new tab)

  5. Histon-Deacetylase Inhibitoren (HDACi) als apoptoseinduzierende und proliferationsinhibierende Substanzen im Zellkulturmodell der akuten lymphoblastischen Leukämie (ALL) im Kindesalter

    In dieser Arbeit wurden unterschiedliche HDACi bezüglich ihrer histonacetylierenden und zytotoxischen Wirkung auf unterschiedliche ALL Zelllinien untersucht und charakterisiert. Als Methoden kamen dabei Zellkultur, Western Blot gegen acetyliertes Histon H4, durchflusszytometrische Apoptosemessung …

    fu-berlin Repository record for Histon-Deacetylase Inhibitoren (HDACi) als apoptoseinduzierende und proliferationsinhibierende Substanzen im Zellkulturmodell der akuten lymphoblastischen Leukämie (ALL) im Kindesalter (opens in a new tab)

  6. Elucidating Novel Mechanisms and Pathways of Pathogenesis, HDACi Resistance, and Disease Progression in B and T Cell Lymphomas through Integrated ‘omics Analyses

    … treated with histone deacetylase inhibitors (HDACi), which broadly affect the chromatin landscape and protein acetylation, but only 30% of patients respond to drug treatment. We defined differences in histone acetylation of regulatory elements and target gene expression in HDACi-sensitive …

    wustl Repository record for Elucidating Novel Mechanisms and Pathways of Pathogenesis, HDACi Resistance, and Disease Progression in B and T Cell Lymphomas through Integrated ‘omics Analyses (opens in a new tab)

  7. Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells

    Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a …

    nus Repository record for Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells (opens in a new tab) Download file for Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells (opens in a new tab)

  8. The effect of histone deacetylase inhibitors on SRC and BCL2L1 gene expression and a potential role for phosphatases in their transcriptional repression

    Histone Deacetylase Inhibitors (HDACi) are a new class of chemotherapeutics which have shown promise in pre-clinical and clinical settings. HDACi have been shown to act by re-programming gene expression, with the transcription of some genes such as p21WAF1 being activated, while others like SRC and …

    sask Repository record for The effect of histone deacetylase inhibitors on SRC and BCL2L1 gene expression and a potential role for phosphatases in their transcriptional repression (opens in a new tab)

  9. Targeted histone deacetylase inhibition

    Histone deacetylase (HDAC) inhibitors (HDACi) have demonstrated a wealth of biological effects, including anti-proliferative, anti-inflammatory, anti-parasitic, and cognition-enhancing activities. The recent FDA approvals of the inhibitors SAHA and FK-228 have validated HDACi clinical use in …

    gatech Repository record for Targeted histone deacetylase inhibition (opens in a new tab)

  10. Targeted delivery of histone deacetylase inhibitors for use in cancer therapy

    … of different classes of HDAC inhibitors (HDACi) as promising therapeutic agents in cancer therapy. These HDACi are anticpated to accumulate at the site of tumor due to selective tissue/cell distribution conferred on them by ligands, known to accumulate in certain tissues or target …

    gatech Repository record for Targeted delivery of histone deacetylase inhibitors for use in cancer therapy (opens in a new tab)

  11. Improving histone deacetylase inhibition therapy through isoform selectivity and targeted delivery

    … approved histone deacetylase inhibitors (HDACi) are pan-inhibitors thus inhibiting all 11 zinc dependent HDAC isoforms including those not involved in tumorigenesis. These inhibitors are also associated with various side effects including a potentially fatal cardiotoxicity. To address …

    gatech Repository record for Improving histone deacetylase inhibition therapy through isoform selectivity and targeted delivery (opens in a new tab)

  12. Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma

    … tissue sarcoma Histone deactylase inhibitors (HDACi) are a new class of anticancer therapeutics; however, little is known about HDACi or the individual contribution of HDAC isoform activity in soft tissue sarcoma (STS). We investigated the potential efficacy of HDACi as monotherapy and in …

    uthsc Repository record for Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma (opens in a new tab)

  13. Effects of Histone Deacetylase Inhibitors on the Maintenance of Midbrain Neurons and Glia

    … demonstrate that histone deacetylase inhibitor (HDACI) treatment of differentiated midbrain neurons in culture results in an overall destabilization of neuronal phenotype, which leads to caspase-independent cell death. GFAP positive astrocytes are refractory to the effects of HDACI treatment, …

    toronto-retro Repository record for Effects of Histone Deacetylase Inhibitors on the Maintenance of Midbrain Neurons and Glia (opens in a new tab)

  14. Novel approaches towards the discovery of tumor-selective histone deacetylase inhibitors

    … novel series of histone deacetylase inhibitors (HDACi). Under the DML approach, bifunctional compounds capable of binding to both histone deacetylase and cyclooxygenase enzymes were made. A subset of the bifunctional compounds was significantly less toxic towards healthy cells compared to the US …

    gatech Repository record for Novel approaches towards the discovery of tumor-selective histone deacetylase inhibitors (opens in a new tab)

  15. How breast cancer cells survive the epigenetic disruption caused by histone deacetylase inhibitors

    Histone deacetylase inhibitors (HDACi) have had a patchy history as anti-cancer treatments, only showing efficacy against specific haematological tumours. They have as yet shown no benefit when used in solid tumours. Previous work in our lab has shown that a specific transcriptional mechanism …

    birmingham Download PDF for How breast cancer cells survive the epigenetic disruption caused by histone deacetylase inhibitors (opens in a new tab)

  16. Epigenetic Mechanisms Governing Behavioral Reprogramming In The Ant Camponotus Floridanus

    … and Minors with histone deacetylase inhibitors (HDACi), and CBP-dependent histone acetyl transferase inhibitors (HATi). We observed foraging enhancement after HDACi, and foraging suppression after HATi in Minors. Curiously, we did not observe increased foraging in HDACi treated mature (~30d) …

    penn Repository record for Epigenetic Mechanisms Governing Behavioral Reprogramming In The Ant Camponotus Floridanus (opens in a new tab)

  17. Histone deacetylase inhibitors modulate human polyomavirus JC replication

    … regulation. Histone deacetylase inhibitors (HDACi) have been demonstrated to increase rearranged JCPyV replication in a transfection model and are candidates for latency reversal agents in HIV treatment. The potential for these HDACi to reactivate HIV suggests the possibility of reactivating …

    hawaii Repository record for Histone deacetylase inhibitors modulate human polyomavirus JC replication (opens in a new tab)

  18. Elucidating the mechanism of action of novel small molecule activators of differentiation in acute myeloid leukemic cells

    … lines, clinical histone deacetylase inhibitors (HDACi) and some novel derivatives were observed to cause an upregulation in CD11b expression. These were further validated by a change in cell morphology and a block in proliferation, with a cell cycle arrest at G1 phase. The novel derivatives were …

    oxford Repository record for Elucidating the mechanism of action of novel small molecule activators of differentiation in acute myeloid leukemic cells (opens in a new tab)

  19. Elucidation of the signaling pathways regulating Naip expression

    … with NaB's histone deacetylase inhibitor (HDACi) capacity underlying Naip induction, and supported by induction of Naip using another potent HDACi, Trichostatin A. We demonstrate that Naip induction following HDACi treatment is concomitant with G 1/G0 cell cycle arrest, p21 induction and …

    ottawa-retro Repository record for Elucidation of the signaling pathways regulating Naip expression (opens in a new tab)

  20. Epigenetic approaches: the emerging role of histone deacetylase inhibitors (HDACis) in promoting dental pulp cell repair mechanisms in vitro

    … using histone-deacetylase-inhibitors (HDACis), which relax its structure and modulate transcription. This project investigated regenerative-associated HDACi effects in vitro on a cell-line and primary dental-pulp-cells (DPCs), using proliferation, viability, mineralisation, …

    birmingham Download PDF for Epigenetic approaches: the emerging role of histone deacetylase inhibitors (HDACis) in promoting dental pulp cell repair mechanisms in vitro (opens in a new tab)

Page 1 of 8